Company Filing History:
1 out of 93 
1 out of 291 
1 out of 5,324 
Years Active: 2010-2016
Title: Edward Keystone: Innovator in Rheumatoid Arthritis Treatment
Introduction
Edward Keystone is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of rheumatoid arthritis. With a total of 2 patents, his work focuses on innovative methods and compositions that enhance the efficacy of treatments for this debilitating condition.
Latest Patents
Keystone's latest patents include groundbreaking inventions aimed at improving the treatment of rheumatoid arthritis. One of his notable patents is titled "Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis." This invention provides methods, uses, and compositions for treating rheumatoid arthritis using TNF-α inhibitors, such as human TNF-α antibodies. It also describes methods for determining the efficacy of these inhibitors in patients. Another significant patent is "Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis." This invention introduces a novel cell that serves as a precursor to fibroblast-like synovial cells. It also outlines methods for diagnosing and monitoring rheumatoid arthritis and osteoarthritis through various profiles of gene and protein expression.
Career Highlights
Throughout his career, Edward Keystone has worked with esteemed organizations, including AbbVie Biotechnology Ltd and the University Health Network. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical research.
Collaborations
Keystone has collaborated with notable colleagues such as Hartmut Kupper and Jeffrey Kent. These partnerships have further enriched his research and innovation efforts in the medical field.
Conclusion
Edward Keystone's contributions to the treatment of rheumatoid arthritis through his innovative patents highlight his dedication to improving patient outcomes. His work continues to influence the medical community and offers hope for those affected by this condition.